Back to catalogue
BiologicalAlzheimer's & Neurological Medicines
NeuralCIM®
Intranasal neuroprotective therapy (recombinant erythropoietin) studied for mild-to-moderate Alzheimer's disease.
Product information
NeuroEPO-based intranasal neuroprotective therapy researched by CIGB.
Indications
Mild-to-moderate Alzheimer's disease; under study for other neurodegenerative conditions.
Formulation
Intranasal spray containing recombinant human erythropoietin (NeuroEPO).
Administration
Intranasal, daily, under medical supervision.
Precautions
Use under specialist neurological supervision. Safety in pregnancy not established.
Product information
- Manufacturer
- CIGB, Havana
- Regulatory status
- Investigational — clinical trials in Cuba and Argentina
